Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy

Bibliographic Details
Main Authors:	Elliott, K, Watkins, H, Redwood, C
Format:	Journal article
Published:	2000

Similar Items

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
by: Elliott, K, et al.
Published: (2000)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
by: Robinson, P, et al.
Published: (2002)

A troponin I mutant known to cause hypertrophic cardiomyopathy shows reduced inhibition of Ca2+ independent tension
by: Burton, D, et al.
Published: (2000)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
by: Redwood, C, et al.
Published: (2001)

Two mutations in human cardiac troponin I known to cause hypertrophic cardiomyopathy have different effects on cardiac muscle contraction
by: Burton, D, et al.
Published: (2000)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
by: Burton, D, et al.
Published: (2002)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
by: Burton, D, et al.
Published: (2002)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

Investigating the Effect of Cardiomyopathy-Causing Mutations in Cardiac Troponin-T on Calcium Buffering In Situ
by: Robinson, P, et al.
Published: (2010)

Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.
by: Redwood, C, et al.
Published: (2000)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
by: Robinson, P, et al.
Published: (2007)

DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation.
by: Preston, L, et al.
Published: (2007)

Dilated cardiomyopathy causing mutations in cardiac troponin T (TNT), cardiac troponin C (TNC), and alpha tropomyosin (TM) reduce CA(2+) sensitivity and maximum calcium activation
by: Redwood, C, et al.
Published: (2004)

Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
by: Bayliss, C, et al.
Published: (2013)

Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy.
by: Mogensen, J, et al.
Published: (2004)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
by: Robinson, P, et al.
Published: (2003)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
by: Robinson, P, et al.
Published: (2007)

Hypertrophic and dilated cardiomyopathycausing mutations of troponin and alpha-tropomyosin have opposite effects on thin filament calcium binding
by: Robinson, P, et al.
Published: (2007)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
by: Preston, L, et al.
Published: (2006)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation
by: Messer, A, et al.
Published: (2016)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
by: Mirza, M, et al.
Published: (2004)

Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy
by: Stefanie Hasler, et al.
Published: (2016-03-01)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
by: Gommans Frank, et al.
Published: (2013-01-01)

Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function.
by: Robinson, P, et al.
Published: (2007)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
by: Carballo, S, et al.
Published: (2006)

Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay.
by: Bing, W, et al.
Published: (2000)

Focus on cardiac troponin complex: From gene expression to cardiomyopathy
by: Rosetta Ragusa, et al.
Published: (2024-11-01)

Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico
by: Zeyu Yang, et al.
Published: (2024-12-01)

Functional effects of the DCM mutant Gly159Asp troponin C in skinned muscle fibres.
by: Preston, L, et al.
Published: (2007)

High-sensitive cardiac troponin T and NT-proBNP are associated with the left ventricular apical thickness in apical hypertrophic cardiomyopathy
by: Meng Zhang, et al.
Published: (2025-01-01)

Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico
by: Yang, Z, et al.
Published: (2024)

Ca2+regulatory properties of a truncated troponin T that causes FHC depend on the ratio of mutant to wild-type peptide.
by: Redwood, C, et al.
Published: (2000)

Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
by: Carballo, S, et al.
Published: (2009)

Mutations in fast skeletal troponin I, troponin T and beta-tropomyosin that cause distal arthrogryposis all enhance thin filament activation
by: Robinson, P, et al.
Published: (2005)

Cardiac troponin I is a potential novel substrate for AMP-activated protein kinase
by: Oliveira, S, et al.
Published: (2007)

Exercise‐Induced Cardiac Troponin I Elevation Is Associated With Regional Alterations in Left Ventricular Strain in High‐Troponin Responders
by: Christine Bjørkvik Erevik, et al.
Published: (2024-08-01)

AMP-Activated Protein Kinase Phosphorylates Cardiac Troponin I and Alters Contractility of Murine Ventricular Myocytes
by: Oliveira, S, et al.
Published: (2012)

AMP-Activated protein kinase phosphorylates cardiac troponin i and alters contractility of murine ventricular myocytes
by: Oliveira, S, et al.
Published: (2012)

AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes.
by: Oliveira, S, et al.
Published: (2012)